PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue.
about
Novel Browning Agents, Mechanisms, and Therapeutic Potentials of Brown Adipose Tissue.Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.C-terminus of HSC70-Interacting Protein (CHIP) Inhibits Adipocyte Differentiation via Ubiquitin- and Proteasome-Mediated Degradation of PPARγ.RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network.Structural homologies between phenformin, lipitor and gleevec aim the same metabolic oncotarget in leukemia and melanoma.Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic MicePosttranslational Modifications of Lipid-Activated Nuclear Receptors: Focus on Metabolism.Distinct but complementary contributions of PPAR isotypes to energy homeostasis.Biology and pathological implications of brown adipose tissue: promises and caveats for the control of obesity and its associated complications.Integrative analysis of super enhancer SNPs for type 2 diabetes.Dietary Quercetin Attenuates Adipose Tissue Expansion and Inflammation and Alters Adipocyte Morphology in a Tissue-Specific Manner.Homeobox a5 Promotes White Adipose Tissue Browning Through Inhibition of the Tenascin C/Toll-Like Receptor 4/Nuclear Factor Kappa B Inflammatory Signaling in Mice.Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice.CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone lossImatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver
P2860
Q30238919-BAFA9658-5846-406B-B965-AEF3FF3B92FFQ33916179-55C53533-963D-413A-8AD0-A0EA810C5A50Q37563337-E8BBB425-ECAD-46D3-8F99-8EB5106D0D9DQ38652671-05C6A61A-0771-4307-985B-DBEFE916AF3DQ38707129-7AAC778D-535B-4278-BBFF-6195A385CA6BQ38747073-200DB21C-A42D-463B-98D2-95837C9D46D2Q39031477-164E9525-77CC-491E-9291-36B7BDB12568Q39214885-A52A762B-63C5-42D5-9458-9D1CB15E8F08Q47259082-818E1944-C020-4882-8B8C-FAA07A90FE10Q48133244-92B5188D-9390-4871-B6CC-13BF77A8F7FAQ51732516-6CBA9198-A7AA-4C58-92AA-524FE82E5DFEQ52590761-81809E29-E98D-4686-83CE-708B07A49149Q55691519-C460E98A-C2C7-43D9-A1EA-4734653BEE21Q57497106-804750FB-1129-42B5-A1E7-33B4C504D4A2Q58548865-DA2ACCA1-B07A-4F30-919D-0001C750C977
P2860
PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PPARγ Antagonist Gleevec Impro ...... wning of White Adipose Tissue.
@en
PPARγ Antagonist Gleevec Impro ...... wning of White Adipose Tissue.
@nl
type
label
PPARγ Antagonist Gleevec Impro ...... wning of White Adipose Tissue.
@en
PPARγ Antagonist Gleevec Impro ...... wning of White Adipose Tissue.
@nl
prefLabel
PPARγ Antagonist Gleevec Impro ...... wning of White Adipose Tissue.
@en
PPARγ Antagonist Gleevec Impro ...... wning of White Adipose Tissue.
@nl
P2093
P2860
P356
P1433
P1476
PPARγ Antagonist Gleevec Impro ...... wning of White Adipose Tissue.
@en
P2093
David P Marciano
Eun-Sun Kim
Eung-Kyun Kim
Hyug Moo Kwon
Hyun-Jun Jang
In Hee Lee
Ja Young Koo
Jang Hyun Choi
Ji-Eun Jung
P2860
P304
P356
10.2337/DB15-1382
P407
P577
2016-01-06T00:00:00Z